Landmark study generated Mature human insulin-producing pancreatic beta cells from stem cells in vitro
On Oct. 9, 2014, a landmark study led by Douglas Melton from Harvard University successfully generated functional, mature human…
The Jackson Laboratory for Genomic Medicine opened its doors
On Oct. 7, 2014, The Jackson Laboratory opened a state-of-the-art genomics research center on the campus of the…
Biotechnology | Disease | FDA | NIH | Non-Profit Research | Pharmaceutical | Vaccine
CDC published ACIP recommendations for use of PCV13 and PPSV23 vaccines in adults age 65 and older
On Sept. 19, 2014, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
University of Missouri School of Medicine received $2.4 million gift to funds endowed faculty chair in oncology
On Aug. 21, 2014, Mark McAndrew, a resident of McKinney, Texas, gave $2.4 million to the University of…
Top U.S. research institutions announced major neuroscience collaboration
On Aug. 4, 2014, the Allen Institute for Brain Science, California Institute of Technology, New York University School…
Artificial Intelligence | Biology | Biotechnology | Disease | Marine Science | Non-Profit Research | Therapeutics
CSHL received $50 million to establish Simons Center for Quantitative Biology
On Jul. 7, 2014, Cold Spring Harbor Laboratory (CSHL) announced a $50 million gift from Jim and Marilyn…
Genentech announced a definitive agreement to acquire Seragon Pharmaceuticals
On Jul. 1, 2014, Genentech entered into an agreement to acquire Seragon Pharmaceuticals, a privately held biotechnology company…
Biotechnology | CDC | Disease | NIH | Non-Profit Research | Therapeutics | Vaccine
CDC published ACIP’s recommendations for use of MenACWY-CRM vaccine in children age 2-23 months at increased risk for meningococcal disease
On Jun. 20, 2014, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
Grifols opened state-of-the-art facility in Clayton to advance treatment of rare and life-threatening diseases
On Jun. 17, 2014, Grifols opened state-of-the-art North Fractionation Facility (NFF) in Clayton, NC, where production capacity of…
Biotechnology | Disease | FDA | Therapeutics
Omeros received FDA Approval of Omidria
On Jun. 2, 2014, Omeros received U.S. Food and Drug Administration (FDA) approval of Omidria for use in…
Stanford Medicine researchers found that a gene variant puts women at higher risk of Alzheimer’s than it does men
On Apr. 14, 2014, Stanford Medicine researchers announced a study that found a gene variant puts women at…
DNA was isolated from the deadly 1849 cholera outbreak in Philadelphia
On Jan. 9, 2014, DNA was isolated from a 165-year-old intestine of a cholera victim from Philadelphia – …
The first-ever living, three-dimensional human arrhythmic heart tissue is bioengineered at the University of Toronto
On Nov. 20, 2013, researchers at the University of Toronto’s Institute of Biomaterials & Biomedical Engineering and the…
Largest international study of Alzheimer’s genes was published
On Oct. 28, 2013, Columbia University Medical Center announced publication of a Meta-analysis of 74,046 individuals that identified…
A second $10 million gift from Jerre and Mary Joy Stead advances children’s medicine at the University of Iowa
On Oct. 24, 2013, the University of Iowa (IA) announced a second $10 million gift commitment from Jerre…
Kern Family donated $100 million to Mayo Clinic to transform health care
On Oct. 23, 2013, the Mayo Clinic announced that Robert and Patricia Kern have given $100 million to…
Myron Cohen received the North Carolina Award for Science
On Oct. 22, 2013 Myron Cohen received the North Carolina Award for Science. Dr. Cohen is a University…
UNMC named new cancer center the Fred & Pamela Buffett Cancer Center
On Jun. 7, 2013, the University of Nebraska Board of Regents approved renaming the UNMC Eppley Cancer Center…
World Ovarian Cancer Day was established
On May 8, 2013, was the first World Ovarian Cancer Day. On this day, ovarian cancer organizations from…
Biotechnology | COVID-19 | Diagnostics | Disease | Genomics | Therapeutics
The Human Genome Project was completed
On Apr. 13, 2003, the International Human Genome Sequencing Consortium announced the completion of the Human Genome Project…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics
Genentech drug Kadcyla (ado-trastuzumab emtansine) was approved
On Feb. 22, 2013, the U.S. Food and Drug Administration (FDA) announced they had approved Genentech’s licensed ado-trastuzumab…
Sanford Health acquired Hematech
On Jan. 4, 2013, Sanford Health announced the acquisition of Sioux Falls-based biotech company Hematech, a subsidiary of…
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders merged three of the four subcategories of possible autistic disorder
In 2013, the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders merged three of the…
GDF-11 was discovered to reverse cardiac hypertrophy
In 2013, Harvard Medical School researchers announced they had discovered that GDF-11 reverses cardiac hypertrophy, or thickening of…
The Connecticut Challenge Survivorship Clinic Opened at Yale Cancer Center
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
A new phlebovirus (Heartland virus) associated with severe febrile illness in Missouri published
On Aug. 30, 2012, a new phlebovirus, discovered in northwestern Missouri by Dr. Scott Folk of Heartland Regional…
The FDA’s “Breakthrough Therapy Designation” was created
On Jul. 9, 2012, the FDA created the “Breakthrough Therapy Designation” that expedites development and review of drugs…
Biotechnology | Disease | FDA | Vaccine
FDA approved HibMenCY vaccine for infants
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
Genentech drug Perjeta (pertuzumab) was approved
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
The U.S. Senate declared May 16, 2012 as Hereditary Angioedema Awareness Day (HAE)
ON May 16, 2012, the U.S. Senate unanimously passed a resolution (S. Res. 286) recognizing May 16, 2012,…